Stocks › DBVT
DBV Technologies S.A.
DBVT·Nasdaq·USD
$9.98
-0.46 (-4.41%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
DBVT
DBV Technologies S.A. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
DBVTS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of DBVT by members of U.S. Congress · 6 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 James B. RenacciHouse · R · OH |
DBVTDBV Technologies S.A. · Stock |
Sale $15,001 - $50,000 |
Dec 21, 2017 | Dec 15, 2017 | Filing ↗ |
| James B. RenacciHouse · R · OH |
DBVTDBV Technologies S.A. · Stock |
Purchase $1,001 - $15,000 |
Mar 23, 2016 | Mar 8, 2016 | Filing ↗ |
| James B. RenacciHouse · R · OH |
DBVTDBV Technologies S.A. · Stock |
Purchase $1,001 - $15,000 |
Feb 8, 2016 | Jan 29, 2016 | Filing ↗ |
| James B. RenacciHouse · R · OH |
DBVTDBV Technologies S.A. · Stock |
Purchase $1,001 - $15,000 |
Jan 27, 2016 | Jan 11, 2016 | Filing ↗ |
| James B. RenacciHouse · R · OH |
DBVTDBV Technologies S.A. · Stock |
Sale $1,001 - $15,000 |
Dec 21, 2015 | Dec 9, 2015 | Filing ↗ |
| James B. RenacciHouse · R · OH |
DBVTDBV Technologies S.A. · Stock |
Purchase $1,001 - $15,000 |
Nov 23, 2015 | Nov 10, 2015 | Filing ↗ |
Whale Activity
Position changes in DBVT reported for 2026-06-30 by 5 tracked institutional filers
- Increased0
- New3
- Held1
- Decreased1
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 267.8K | $4.4M | decreased |
| CITADEL ADVISORS LLC | 22.8K | $374K | new |
| Point72 Asset Management, L.P. | 12.1K | $199K | new |
| TWO SIGMA INVESTMENTS, LP | 11.6K | $191K | new |
| BlackRock, Inc. | 2 | $33 | held |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by DBVT insiders, by quarter · Form 4
Recent Insider Transactions
37 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Mohideen PharisChief Medical Officer | Sale | −464 | n/c | — | Jul 29, 2026 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −534 | n/c | — | Jan 29, 2026 | Form 4 ↗ |
| EPIC Bpifrance | Sale | −1.3M | n/c | — | Dec 18, 2025 | Form 4 ↗ |
| EPIC Bpifrance | Sale | −40.0K | n/c | — | Dec 17, 2025 | Form 4 ↗ |
| EPIC Bpifrance | Sale | −2.0M | n/c | — | Dec 17, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Grant / award | +44.0K | $0.00 | $0 | Nov 21, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −1,624 | n/c | — | Nov 21, 2025 | Form 4 ↗ |
| Trapp Kevin MichaelChief Commercial Officer | Grant / award | +55.0K | $0.00 | $0 | Nov 21, 2025 | Form 4 ↗ |
| Boucinha VirginieChief Financial Officer | Grant / award | +32.0K | $0.00 | $0 | Nov 21, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −6,496 | n/c | — | Nov 20, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −464 | n/c | — | Jul 29, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −397 | n/c | — | May 22, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −600 | n/c | — | Jan 30, 2025 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −565 | $0.57 | $322 | Nov 25, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −342 | $0.53 | $181 | Nov 22, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −2,350 | $0.54 | $1K | Nov 21, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Grant / award | +35.0K | $0.00 | $0 | Nov 21, 2024 | Form 4 ↗ |
| Boucinha VirginieChief Financial Officer | Grant / award | +19.0K | $0.00 | $0 | Nov 21, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −1,785 | $0.98 | $2K | Jul 29, 2024 | Form 4 ↗ |
| Mohideen PharisChief Medical Officer | Sale | −660 | n/c | — | May 24, 2024 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding DBVT · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Artisan International Small-Mid Fund Artisan Partners Funds Inc. | 840.3K | $13.8M | 0.54% | Jun 30, 2026 |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 428.8K | $5.8M | 0.26% | Jul 31, 2026 |
| Tax-Managed U.S. Mid & Small Cap Fund RUSSELL INVESTMENT CO | 45.1K | $947K | 0.05% | Apr 30, 2026 |
| AdvisorShares Dorsey Wright ADR ETF AdvisorShares Trust | 43.7K | $716K | 1.72% | Jun 30, 2026 |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT CO | 22.7K | $307K | 0.03% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 8,897 | $170K | 0.00% | May 31, 2026 |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 5,834 | $96K | 0.04% | Jun 30, 2026 |
| Steward Values Enhanced International Fund Steward Funds Inc | 4,051 | $55K | 0.02% | Jul 31, 2026 |
| ActivePassive International Equity ETF Trust for Professional Managers | 2,245 | $43K | 0.00% | May 31, 2026 |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 2,973 | $40K | 0.47% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list DBVT's shares (CUSIP 23306J309), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- MPM BioImpact LLCSCHEDULE 13G/A · passive (13G) · 18.3M shares6.2%
Aug 14, 2026 · ↗ - RA Capital Healthcare Fund, L.P.SCHEDULE 13G · passive (13G) · 18.3M shares5.8%
Aug 6, 2026 · ↗ - Rajeev ShahSCHEDULE 13G · passive (13G) · 18.3M shares5.8%
Aug 6, 2026 · ↗ - Peter KolchinskySCHEDULE 13G · passive (13G) · 18.3M shares5.8%
Aug 6, 2026 · ↗ - RA Capital Management, L.P.SCHEDULE 13G · passive (13G) · 18.3M shares5.8%
Aug 6, 2026 · ↗ - MPM BioImpact LLCSCHEDULE 13G/A · passive (13G) · 26.1M shares8.8%
May 15, 2026 · ↗ - Artisan Partners Limited PartnershipSCHEDULE 13G/A · passive (13G) · 2.2M shares3.7%
May 13, 2026 · ↗ - Artisan Investments GP LLCSCHEDULE 13G/A · passive (13G) · 2.2M shares3.7%
May 13, 2026 · ↗ - Artisan Partners Holdings LPSCHEDULE 13G/A · passive (13G) · 2.2M shares3.7%
May 13, 2026 · ↗ - Artisan Partners Asset Management Inc.SCHEDULE 13G/A · passive (13G) · 2.2M shares3.7%
May 13, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming dbv technologies as client
- WINNING STRATEGIES WASHINGTONDBV TECHNOLOGIES · 2026 Q2 · HCR$30K
Filing ↗ - WINNING STRATEGIES WASHINGTONDBV TECHNOLOGIES · 2026 Q1 · HCR$30K
Filing ↗ - WINNING STRATEGIES WASHINGTONDBV TECHNOLOGIES · 2025 Q4 · HCR$40K
Filing ↗ - WINNING STRATEGIES WASHINGTONDBV TECHNOLOGIES · 2025 Q3 · HCR$40K
Filing ↗ - WINNING STRATEGIES WASHINGTONDBV TECHNOLOGIES · 2025 Q2 · HCR$40K
Filing ↗
Government Contracts
Federal awards to DBV Technologies S.A. · USAspending
No federal contract awards found for DBV Technologies S.A..
U.S. Patents
Recent USPTO applications naming DBV Technologies S.A.
No USPTO patent applications found for DBV Technologies S.A..
Annual Financials
From DBVT's 10-K filings · XBRL
No annual XBRL figures on record for DBVT. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 1-for-5Reverse splitNov 29, 2024
- 1-for-2Reverse splitJun 7, 2024
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 8.01, 9.01Other eventsSep 30, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 16, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJun 29, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeJun 5, 2026
EDGAR ↗ - 8-K · Items 5.03, 5.07, 9.01Bylaw amendment · Shareholder voteJun 3, 2026
EDGAR ↗ - 8-K · Items 5.02, 9.01Officer / director changeMay 5, 2026
EDGAR ↗
About DBV Technologies S.A.
From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersCHATILLON
IncorporatedI0
SEC CIK0001613780 ↗